adin
pharmaco (nz) ltd - desmopressin acetate trihydrate 0.1mg equivalent to 0.089 mg free base - tablet - 0.1 mg - active: desmopressin acetate trihydrate 0.1mg equivalent to 0.089 mg free base excipient: lactose monohydrate magnesium stearate potato starch povidone
minirin
pharmaco (nz) ltd - desmopressin acetate trihydrate 0.1mg equivalent to 0.089 mg free base - tablet - 0.1 mg - active: desmopressin acetate trihydrate 0.1mg equivalent to 0.089 mg free base excipient: ethanol lactose monohydrate magnesium stearate potato starch povidone purified water
adin
pharmaco (nz) ltd - desmopressin acetate trihydrate 0.1 mg/ml equivalent to 0.089 mg desmopressin free base - nasal spray solution - 0.1 mg/ml - active: desmopressin acetate trihydrate 0.1 mg/ml equivalent to 0.089 mg desmopressin free base excipient: benzalkonium chloride citric acid monohydrate dibasic sodium phosphate dihydrate sodium chloride water for injection
minirin
pharmaco (nz) ltd - desmopressin acetate trihydrate 0.1mg equivalent to 0.089 mg desmopressin free base - nasal spray solution - 10 mcg/dose - active: desmopressin acetate trihydrate 0.1mg equivalent to 0.089 mg desmopressin free base excipient: benzalkonium chloride citric acid monohydrate dibasic sodium phosphate dihydrate sodium chloride water for injection
minirin
pharmaco (nz) ltd - desmopressin acetate trihydrate 100 µg/ml equivalent to 8 9µg/ml desmopressin free base - nasal drops - 100 mcg/ml - active: desmopressin acetate trihydrate 100 µg/ml equivalent to 8 9µg/ml desmopressin free base excipient: chlorobutanol hemihydrate hydrochloric acid purified water sodium chloride - minirin nasal drops solution is indicated for the treatment of central diabetes insipidus and for establishing renal concentration capacity testing.
minirin
pharmaco (nz) ltd - desmopressin acetate trihydrate 0.2mg equivalent to 0.178 mg free base - tablet - 0.2 mg - active: desmopressin acetate trihydrate 0.2mg equivalent to 0.178 mg free base excipient: ethanol lactose monohydrate magnesium stearate potato starch povidone purified water - the treatment of primary nocturnal enuresis in patients (from 5 years of age) with normal ability to concentrate urine.
adin
pharmaco (nz) ltd - desmopressin acetate trihydrate 0.2mg equivalent to 0.178 mg free base - tablet - 0.2 mg - active: desmopressin acetate trihydrate 0.2mg equivalent to 0.178 mg free base excipient: lactose monohydrate magnesium stearate potato starch povidone
desmopressin teva 0.1 mg
teva israel ltd - desmopressin acetate - tablets - desmopressin acetate 0.1 mg - desmopressin - desmopressin - desmopressin teva tablets are indicated for central diabetes insipidus, nocturnal enuresis ( in patients from 5 years of age with normal ability to concentrate the urine) and for symptomatic treatment of nocturia in adults associated with nocturnal polyuria, i.e. nocturnal urine production exceeding bladder capacity. the treatment must be started befor the age of 65.
desmopressin teva 0.2 mg
teva israel ltd - desmopressin acetate - tablets - desmopressin acetate 0.2 mg - desmopressin - desmopressin - desmopressin teva tablets are indicated for central diabetes insipidus, nocturnal enuresis ( in patients from 5 years of age with normal ability to concentrate the urine) and for symptomatic treatment of nocturia in adults associated with nocturnal polyuria, i.e. nocturnal urine production exceeding bladder capacity. the treatment must be started befor the age of 65.
desmopressin-ph&t
aft pharmaceuticals ltd - desmopressin acetate trihydrate 0.6mg equivalent to desmopressin 0.089 mg/ml; - nasal spray solution - 0.1 mg/ml - active: desmopressin acetate trihydrate 0.6mg equivalent to desmopressin 0.089 mg/ml excipient: chlorobutanol hemihydrate hydrochloric acid nitrogen purified water sodium chloride